Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...
Cumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback